Aperam is trading at €38.92, up +4.23%; no reliable report has identified a specific catalyst for the October 9 move.

  • The latest company update said Q3 adjusted EBITDA would be below Q2’s €130 million, citing weak European demand and higher energy costs—a sign of pressure, not a clear explanation for the gain.
  • Trading volume and other activity details were unavailable, so the reason for the rise remains unconfirmed.